Evidence map›Paper›PMID 31713830›Full record

ArticleImmunologic research2019

Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency.

Hasibe Artac, Ayca Emsen, Hulya Ucaryilmaz, Halil Haldun Emiroglu, Vedat Uygun, Asbjørg Stray-Pedersen

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Immunologic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hasibe ArtacDepartment of Pediatric Immunology and Allergy, Selcuk University Medical Faculty, Alaeddin Keykubat Kampusu, 42130, Konya, Turkey. hasibeartac@yahoo.com.ORCID http://orcid.org/0000-0002-9807-2605
Ayca EmsenDepartment of Pediatric Immunology and Allergy, Selcuk University Medical Faculty, Alaeddin Keykubat Kampusu, 42130, Konya, Turkey.
Hulya UcaryilmazDepartment of Pediatric Immunology and Allergy, Selcuk University Medical Faculty, Alaeddin Keykubat Kampusu, 42130, Konya, Turkey.
Halil Haldun EmirogluDepartment of Gastroenterology and Hepatology, Selcuk University Medical Faculty, Konya, Turkey.
Vedat UygunDepartment of Pediatric Hematology and Oncology, Medical Park Antalya Hospital, Antalya, Turkey.
Asbjørg Stray-PedersenCenter for Human Immunobiology-Immunology-Allergy-Rhematology, Texas Children Hospital-Baylor College of Medicine, Houston, TX, USA.
Selçuk University · TRAntalya IVF · TRBaylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllograftsColitis, UlcerativeEctodermal DysplasiaHematopoietic Stem Cell TransplantationI-kappa B KinasePrimary Immunodeficiency DiseasesHumansInfantInfliximabMaleI-kappa B KinaseIKBKG protein, humanInfliximab

Identifiers

PMID31713830
OpenAlexW2983780400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.